Task: Answer the multiple choice question.
Query: Which drug exhibits a -2.083% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) COc1ccc(CSc2n[nH]c(C)n2)cc1Br
(b) CCOC(=O)C(C(=O)NCc1ccc(C)cc1)c1ncc(C(F)(F)F)cc1Cl
Answer: b. CCOC(=O)C(C(=O)NCc1ccc(C)cc1)c1ncc(C(F)(F)F)cc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)C(C(=O)NCc1ccc(C)cc1)c1ncc(C(F)(F)F)cc1Cl
CCOC(=O)C(C(=O)NCc1ccc(C)cc1)c1ncc(C(F)(F)F)cc1Cl
ethyl 2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-3-[(4-methylphenyl)methylamino]-3-oxopropanoate